Patents by Inventor Ram Shankar Mani

Ram Shankar Mani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene fusion targeted therapy
    Patent number: 8759301
    Abstract: The present invention relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present invention relates to recurrent gene fusions as clinical targets for prostate cancer.
    Type: Grant
    Filed: February 10, 2011
    Date of Patent: June 24, 2014
    Assignee: The Regents of The University of Michigan
    Inventors: Arul M. Chinnaiyan, Xiaoju Wang, Ram Shankar Mani
  • Gene fusion targeted therapy
    Patent number: 8143232
    Abstract: The present invention relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present invention relates to recurrent gene fusions as clinical targets for prostate cancer.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: March 27, 2012
    Assignee: The Regents of the University of Michigan
    Inventors: Arul M. Chinnaiyan, Jindan Yu, Ram Shankar Mani
  • GENE FUSION TARGETED THERAPY
    Publication number: 20110207675
    Abstract: The present invention relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present invention relates to recurrent gene fusions as clinical targets for prostate cancer.
    Type: Application
    Filed: February 10, 2011
    Publication date: August 25, 2011
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Arul M. Chinnaiyan, Xiaoju Wang, Ram Shankar Mani
  • GENE FUSION TARGETED THERAPY
    Publication number: 20100227910
    Abstract: The present invention relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present invention relates to recurrent gene fusions as clinical targets for prostate cancer.
    Type: Application
    Filed: March 3, 2010
    Publication date: September 9, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Arul M. Chinnaiyan, Jindan Yu, Ram Shankar Mani